Varenicline (CP 526555) is an orally active partial agonist of alpha4beta2 nicotinic acetylcholine receptor (alpha4beta2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of alpha6beta2 nAChR and a full agonist of alpha7beta2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].
Molecular Weight:
211.268
Purity:
99.92
CAS Number:
[249296-44-4]
Formula:
C13H13N3
Target:
nAChR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted